Health Law & Business News

Trump’s Canada Drug Import Plan Can’t Happen Without Big Pharma

Aug. 13, 2019, 10:29 AM

U.S. President Donald Trump’s plan to import cheap Canadian drugs overlooks a crucial fact: it can’t happen without the cooperation of major drugmakers, the very industry he’s trying to undercut.

Even as alarm grows in Canada over the prospect of Americans draining their supply of medicines, there’s little reason to believe the U.S. proposal would worsen the country’s drug shortages. But the fear plays into the hands of the powerful drug companies seeking to protect their U.S. profit margins.

“Instead of attacking the Trump administration for this proposal, it’s easier to make sure that this proposal does not come into...

To read the full article log in. To learn more about a subscription click here.